Antibodies against claudin 18.2 useful in cancer diagnosis
摘要
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.
申请公布号
AU2013258432(A1)
申请公布日期
2014.10.30
申请号
AU20130258432
申请日期
2013.05.06
申请人
GANYMED PHARMACEUTICALS AG;TRON- TRANSLATIONALE ONKOLOGIE AN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH
发明人
SAHIN, UGUR;TURECI, OZLEM;MITNACHT-KRAUS, RITA;WOLL, STEFAN
